Terapia de células t con receptor de antígeno quimérico específico de cd19

Terapia de células T con receptor de antígeno quimérico específico de CD19 La presente invención se refiere a terapia de células T con receptor de antígeno quimérico (CAR) específico de CD19 y a su uso para tratar neoplasias malignas CD19+. The present invention refers to a CD19-specific chimeric an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: YAGÜE RIBES, Jordi, CASTELLÀ CASTELLÀ, María, BORONAT BARADO, Ana, DELGADO GONZÁLEZ, Julio, JUAN OTERO, Manel, PASCAL CAPDEVILA, Mariona, ESTEVE REYNER, Jordi, URBANO ISPIZUA, Álvaro
Format: Patent
Sprache:spa
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator YAGÜE RIBES, Jordi
CASTELLÀ CASTELLÀ, María
BORONAT BARADO, Ana
DELGADO GONZÁLEZ, Julio
JUAN OTERO, Manel
PASCAL CAPDEVILA, Mariona
ESTEVE REYNER, Jordi
URBANO ISPIZUA, Álvaro
description Terapia de células T con receptor de antígeno quimérico específico de CD19 La presente invención se refiere a terapia de células T con receptor de antígeno quimérico (CAR) específico de CD19 y a su uso para tratar neoplasias malignas CD19+. The present invention refers to a CD19-specific chimeric antigen receptor (CAR) T-cell therapy and to its use for treating CD19+ malignancies.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CO2023016940A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CO2023016940A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CO2023016940A23</originalsourceid><addsrcrecordid>eNrjZPALSS1KLMhMVEhJVUg-vDKnNCexWKFEITk_T6EoNTm1oCS_CCSVmFdyeG16al6-QmFpZu7hlUWZyfkKqcUFqcmH16aB2CDtKYaWPAysaYk5xam8UJqbQdnNNcTZQze1ID8eqD4xOTUvtSTe2d_IwMjYwNDM0sTA0ciYOFUAzVg5AQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Terapia de células t con receptor de antígeno quimérico específico de cd19</title><source>esp@cenet</source><creator>YAGÜE RIBES, Jordi ; CASTELLÀ CASTELLÀ, María ; BORONAT BARADO, Ana ; DELGADO GONZÁLEZ, Julio ; JUAN OTERO, Manel ; PASCAL CAPDEVILA, Mariona ; ESTEVE REYNER, Jordi ; URBANO ISPIZUA, Álvaro</creator><creatorcontrib>YAGÜE RIBES, Jordi ; CASTELLÀ CASTELLÀ, María ; BORONAT BARADO, Ana ; DELGADO GONZÁLEZ, Julio ; JUAN OTERO, Manel ; PASCAL CAPDEVILA, Mariona ; ESTEVE REYNER, Jordi ; URBANO ISPIZUA, Álvaro</creatorcontrib><description>Terapia de células T con receptor de antígeno quimérico específico de CD19 La presente invención se refiere a terapia de células T con receptor de antígeno quimérico (CAR) específico de CD19 y a su uso para tratar neoplasias malignas CD19+. The present invention refers to a CD19-specific chimeric antigen receptor (CAR) T-cell therapy and to its use for treating CD19+ malignancies.</description><language>spa</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240205&amp;DB=EPODOC&amp;CC=CO&amp;NR=2023016940A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240205&amp;DB=EPODOC&amp;CC=CO&amp;NR=2023016940A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>YAGÜE RIBES, Jordi</creatorcontrib><creatorcontrib>CASTELLÀ CASTELLÀ, María</creatorcontrib><creatorcontrib>BORONAT BARADO, Ana</creatorcontrib><creatorcontrib>DELGADO GONZÁLEZ, Julio</creatorcontrib><creatorcontrib>JUAN OTERO, Manel</creatorcontrib><creatorcontrib>PASCAL CAPDEVILA, Mariona</creatorcontrib><creatorcontrib>ESTEVE REYNER, Jordi</creatorcontrib><creatorcontrib>URBANO ISPIZUA, Álvaro</creatorcontrib><title>Terapia de células t con receptor de antígeno quimérico específico de cd19</title><description>Terapia de células T con receptor de antígeno quimérico específico de CD19 La presente invención se refiere a terapia de células T con receptor de antígeno quimérico (CAR) específico de CD19 y a su uso para tratar neoplasias malignas CD19+. The present invention refers to a CD19-specific chimeric antigen receptor (CAR) T-cell therapy and to its use for treating CD19+ malignancies.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZPALSS1KLMhMVEhJVUg-vDKnNCexWKFEITk_T6EoNTm1oCS_CCSVmFdyeG16al6-QmFpZu7hlUWZyfkKqcUFqcmH16aB2CDtKYaWPAysaYk5xam8UJqbQdnNNcTZQze1ID8eqD4xOTUvtSTe2d_IwMjYwNDM0sTA0ciYOFUAzVg5AQ</recordid><startdate>20240205</startdate><enddate>20240205</enddate><creator>YAGÜE RIBES, Jordi</creator><creator>CASTELLÀ CASTELLÀ, María</creator><creator>BORONAT BARADO, Ana</creator><creator>DELGADO GONZÁLEZ, Julio</creator><creator>JUAN OTERO, Manel</creator><creator>PASCAL CAPDEVILA, Mariona</creator><creator>ESTEVE REYNER, Jordi</creator><creator>URBANO ISPIZUA, Álvaro</creator><scope>EVB</scope></search><sort><creationdate>20240205</creationdate><title>Terapia de células t con receptor de antígeno quimérico específico de cd19</title><author>YAGÜE RIBES, Jordi ; CASTELLÀ CASTELLÀ, María ; BORONAT BARADO, Ana ; DELGADO GONZÁLEZ, Julio ; JUAN OTERO, Manel ; PASCAL CAPDEVILA, Mariona ; ESTEVE REYNER, Jordi ; URBANO ISPIZUA, Álvaro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CO2023016940A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>YAGÜE RIBES, Jordi</creatorcontrib><creatorcontrib>CASTELLÀ CASTELLÀ, María</creatorcontrib><creatorcontrib>BORONAT BARADO, Ana</creatorcontrib><creatorcontrib>DELGADO GONZÁLEZ, Julio</creatorcontrib><creatorcontrib>JUAN OTERO, Manel</creatorcontrib><creatorcontrib>PASCAL CAPDEVILA, Mariona</creatorcontrib><creatorcontrib>ESTEVE REYNER, Jordi</creatorcontrib><creatorcontrib>URBANO ISPIZUA, Álvaro</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>YAGÜE RIBES, Jordi</au><au>CASTELLÀ CASTELLÀ, María</au><au>BORONAT BARADO, Ana</au><au>DELGADO GONZÁLEZ, Julio</au><au>JUAN OTERO, Manel</au><au>PASCAL CAPDEVILA, Mariona</au><au>ESTEVE REYNER, Jordi</au><au>URBANO ISPIZUA, Álvaro</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Terapia de células t con receptor de antígeno quimérico específico de cd19</title><date>2024-02-05</date><risdate>2024</risdate><abstract>Terapia de células T con receptor de antígeno quimérico específico de CD19 La presente invención se refiere a terapia de células T con receptor de antígeno quimérico (CAR) específico de CD19 y a su uso para tratar neoplasias malignas CD19+. The present invention refers to a CD19-specific chimeric antigen receptor (CAR) T-cell therapy and to its use for treating CD19+ malignancies.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language spa
recordid cdi_epo_espacenet_CO2023016940A2
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title Terapia de células t con receptor de antígeno quimérico específico de cd19
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T06%3A25%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=YAG%C3%9CE%20RIBES,%20Jordi&rft.date=2024-02-05&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECO2023016940A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true